Literature DB >> 25399026

Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.

Anthony O Ahmed1, Gregory P Strauss2, Robert W Buchanan3, Brian Kirkpatrick4, William T Carpenter3.   

Abstract

Studies have supported the validity of the deficit form of schizophrenia (ie, people with primary and enduring negative symptoms). A test of whether that group is a true taxon-that is, a distinct, discontinuous group-has yet to be conducted and the underlying structure of negative symptoms as categorical or dimensional remains undetermined. The present study examined the latent structure of negative and deficit symptoms to determine if a nonarbitrary boundary distinguishes deficit from nondeficit forms of schizophrenia (ie, whether these symptoms reflect a continuous or categorical variable). Schedule for the Deficit Syndrome ratings of 789 individuals with a psychotic disorder were submitted to taxometric and latent variable mixture analyses to test categorical vs dimensional hypotheses of negative symptoms and deficit schizophrenia. Analytic models favored a taxonic structure of negative symptoms and the validity of the deficit/nondeficit classification scheme. Taxometric classification outperformed clinician-based deficit/nondeficit classification in its association with summer birth, male sex, premorbid adjustment, neurocognition, and psychosocial functioning. Within taxon and complement classes, severity scores remained significant predictors of premorbid adjustment, neurocognition, and psychosocial functioning. Thus, although a categorical approach is validated, a hybrid categorical-dimensional conceptualization of negative symptoms also has validity for the prediction of external variables.
© The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  classification; deficit/negative symptoms taxon; hybrid categorical-dimensional model; schedule for the deficit syndrome

Mesh:

Year:  2014        PMID: 25399026      PMCID: PMC4466177          DOI: 10.1093/schbul/sbu163

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  75 in total

1.  Neurological signs and the heterogeneity of schizophrenia.

Authors:  C Arango; B Kirkpatrick; R W Buchanan
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

2.  Clarifying boundary issues in psychopathology: the role of taxometrics in a comprehensive program of structural research.

Authors:  John Ruscio; Ayelet Meron Ruscio
Journal:  J Abnorm Psychol       Date:  2004-02

3.  Comparing the relative fit of categorical and dimensional latent variable models using consistency tests.

Authors:  John Ruscio; Glenn D Walters; David K Marcus; Walter Kaczetow
Journal:  Psychol Assess       Date:  2010-03

Review 4.  Persistent negative symptoms in schizophrenia: an overview.

Authors:  Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-11-10       Impact factor: 9.306

5.  Taxometric analyses of paranoid and schizoid personality disorders.

Authors:  Anthony Olufemi Ahmed; Bradley Andrew Green; Peter Francis Buckley; Megan Elizabeth McFarland
Journal:  Psychiatry Res       Date:  2012-02-28       Impact factor: 3.222

6.  Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophrenia.

Authors:  L Elliot Hong; Ikwunga Wonodi; Matthew T Avila; Robert W Buchanan; Robert P McMahon; Braxton D Mitchell; O Colin Stine; William T Carpenter; Gunvant K Thaker
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-07-05       Impact factor: 3.568

7.  Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment.

Authors:  Silvana Galderisi; Mario Maj; Brian Kirkpatrick; Paola Piccardi; Armida Mucci; Giordano Invernizzi; Alessandro Rossi; Stefano Pini; Antonio Vita; Paolo Cassano; Paolo Stratta; Giovanni Severino; Maria Del Zompo
Journal:  Neuropsychobiology       Date:  2005-07-19       Impact factor: 2.328

8.  The psychiatric symptomatology of deficit schizophrenia: a meta-analysis.

Authors:  Alex S Cohen; Laura A Brown; Kyle S Minor
Journal:  Schizophr Res       Date:  2009-11-03       Impact factor: 4.939

9.  Using taxometric analysis to distinguish a small latent taxon from a latent dimension with positively skewed indicators: the case of involuntary defeat syndrome.

Authors:  John Ruscio; Ayelet Meron Ruscio; Terence M Keane
Journal:  J Abnorm Psychol       Date:  2004-02

10.  Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia.

Authors:  Armida Mucci; Silvana Galderisi; Brian Kirkpatrick; Paola Bucci; Umberto Volpe; Eleonora Merlotti; Fausto Centanaro; Francesco Catapano; Mario Maj
Journal:  Schizophr Res       Date:  2007-03-23       Impact factor: 4.939

View more
  23 in total

1.  Substance Use Disorders in Adolescence Exist along Continua: Taxometric Evidence in an Epidemiological Sample.

Authors:  Richard T Liu
Journal:  J Abnorm Child Psychol       Date:  2017-11

2.  Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning.

Authors:  Buranee Kanchanatawan; Sira Sriswasdi; Supaksorn Thika; Sunee Sirivichayakul; André F Carvalho; Michel Geffard; Marta Kubera; Michael Maes
Journal:  Metab Brain Dis       Date:  2018-03-11       Impact factor: 3.584

3.  Attacking Heterogeneity in Schizophrenia by Deriving Clinical Subgroups From Widely Available Symptom Data.

Authors:  Dwight Dickinson; Danielle N Pratt; Evan J Giangrande; MeiLin Grunnagle; Jennifer Orel; Daniel R Weinberger; Joseph H Callicott; Karen F Berman
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

4.  Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis.

Authors:  Cynthia Z Burton; Ivy F Tso; Ricardo E Carrión; Tara Niendam; Steven Adelsheim; Andrea M Auther; Barbara A Cornblatt; Cameron S Carter; Ryan Melton; Tamara G Sale; Stephan F Taylor; William R McFarlane
Journal:  Schizophr Res       Date:  2019-08-06       Impact factor: 4.939

5.  Common Taxonomy of Traits and Symptoms: Linking Schizophrenia Symptoms, Schizotypy, and Normal Personality.

Authors:  David C Cicero; Katherine G Jonas; Kaiqiao Li; Greg Perlman; Roman Kotov
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

Review 6.  Primary, Enduring Negative Symptoms: An Update on Research.

Authors:  Brian Kirkpatrick; Armida Mucci; Silvana Galderisi
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

7.  Network Analysis Reveals Which Negative Symptom Domains Are Most Central in Schizophrenia vs Bipolar Disorder.

Authors:  Gregory Paul Strauss; Farnaz Zamani Esfahlani; Brian Kirkpatrick; Daniel N Allen; James M Gold; Katherine Frost Visser; Hiroki Sayama
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

8.  Neurocognitive impairment in the deficit subtype of schizophrenia.

Authors:  Gagan Fervaha; Ofer Agid; George Foussias; Ishraq Siddiqui; Hiroyoshi Takeuchi; Gary Remington
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-11       Impact factor: 5.270

9.  Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis.

Authors:  Matthew E Hudgens-Haney; Brett A Clementz; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Elliot S Gershon; Sarah K Keedy; John A Sweeney; Florence Gaudoux; Pierre Bunouf; Benoit Canolle; Françoise Tonner; Silvia Gatti-McArthur; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2020-02-11       Impact factor: 9.306

10.  The Behavioral Approach System (BAS) Model of Vulnerability to Bipolar Disorder: Evidence of a Continuum in BAS Sensitivity across Adolescence.

Authors:  Richard T Liu; Taylor A Burke; Lyn Y Abramson; Lauren B Alloy
Journal:  J Abnorm Child Psychol       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.